Historical Stock Price
ETFs Holding ABUS »    ABUS Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
10/10/2017 $7.05 $7.43 $6.95 $7.30 322.00K
10/11/2017 $7.35 $7.90 $7.20 $7.70 605.00K
10/12/2017 $7.80 $7.95 $7.25 $7.40 505.00K
10/13/2017 $7.40 $7.40 $7.10 $7.25 234.50K
10/16/2017 $7.20 $7.38 $7.05 $7.25 203.30K
Arbutus Biopharma is a therapeutic solutions company focused on discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus (HBV) infection. Co.'s HBV pipeline consists of multiple drug candidates, with differing and complementary mechanisms of action. The candidates include: RNAi 1.0 (ARB-1467), which is Co.'s main RNA Interference (RNAi) HBV candidate designed to eliminate HBV surface antigen expression in patients chronically infected with HBV; RNAi 2.0 (ARB-1740), Co.'s follow-on RNAi HBV candidate; and Core Protein/ Capsid Assembly Inhibitors (AB-423), which is being developed as oral therapeutics for the treatment of chronic HBV infection.
ABUS historical stock prices picture
Arbutus Biopharma (ABUS) has the following price history information. Looking back at ABUS historical stock prices for the last five trading days, on October 10, 2017, ABUS opened at $7.05, traded as high as $7.43 and as low as $6.95, and closed at $7.30. Trading volume was a total of 322.00K shares. On October 11, 2017, ABUS opened at $7.35, traded as high as $7.90 and as low as $7.20, and closed at $7.70. Trading volume was a total of 605.00K shares. On October 12, 2017, ABUS opened at $7.80, traded as high as $7.95 and as low as $7.25, and closed at $7.40. Trading volume was a total of 505.00K shares. On October 13, 2017, ABUS opened at $7.40, traded as high as $7.40 and as low as $7.10, and closed at $7.25. Trading volume was a total of 234.50K shares. On October 16, 2017, ABUS opened at $7.20, traded as high as $7.38 and as low as $7.05, and closed at $7.25. Trading volume was a total of 203.30K shares.

ABUS Historical Stock Prices By Date:

ABUS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arbutus Biopharma shares, starting with a $10,000 purchase of ABUS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/17/2007
End date: 10/16/2017
Start price/share: $8.70
End price/share: $7.25
Dividends collected/share: $0.00
Total return: -16.67%
Average Annual Total Return: -1.81%
Starting investment: $10,000.00
Ending investment: $8,329.70
Years: 10.01
Date Close
10/10/2017$7.30
10/11/2017$7.70
10/12/2017$7.40
10/13/2017$7.25
10/16/2017$7.25
ABUS is categorized under the Healthcare sector; below are some other companies in the same sector:

ACAD Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices
ACIU Historical Stock Prices
ACOR Historical Stock Prices
ACRS Historical Stock Prices
ACRX Historical Stock Prices
ACST Historical Stock Prices

ABUS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.